{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000013","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.064629+00:00","generated_at":"2026-06-06T23:45:40.837288+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Lifecore Biomedical receives Nasdaq notice for delayed quarterly and annual filings","bullets":["Nasdaq notified Lifecore on Jan 10, 2024 that it is not compliant with Listing Rule 5250(c)(1) due to delayed Q2 Form 10-Q and continued delays in Form 10-K and Q1 Form 10-Q.","The company had a previously approved compliance plan with an exception period until Feb 12, 2024 to file Form 10-K and Q1 Form 10-Q.","Lifecore plans to submit an updated compliance plan by Jan 25, 2024 to address the Q2 Form 10-Q filing and regain compliance.","The notice has no immediate effect on the listing or trading of LFCR common stock on Nasdaq Global Select Market.","The company continues to work to complete the filings but cannot assure regaining compliance by the deadline."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000013","json":"https://secwatch.observer/filing/0001005286-24-000013.json","markdown":"https://secwatch.observer/filing/0001005286-24-000013.md","text":"https://secwatch.observer/filing/0001005286-24-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000013/0001005286-24-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000013/lndc-20240110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T23:45:40.837288+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"34c9892d50a0e8524a59a94c2499c63ab94df50f","claim":"LIFECORE BIOMEDICAL, INC. DE received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"10-Q for the fiscal quarter ended August 27, 2023 (the “Q1 Form 10-Q” and, together with the Form 10-K and the Q2 Form 10-Q, the “Filings”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Global Select Market. On October 16, 2023, the Company submitted to Nasdaq its compliance plan (the “Compliance Plan”) with respect to the filing of the Form 10-K","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000013/0001005286-24-000013-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}